The correlation of angiogenesis with metastasis in primary cutaneous melanoma: A comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor

Pathology

Volumn 38, Issue 2, 2006, Pages 132-137

  Demirkesen, Cuyan ^a,b   Büyükpinarbaşili, Nur ^a   Ramazanoǧlu, Rana ^a   Oǧuz, Oya ^a   Mandel, Nil Molinas ^a   Kaner, Gültekin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Angiogenesis; BFGF; Cutaneous malignant melanoma; Prognosis; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CELL NUCLEUS MEMBRANE; CHI SQUARE DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MALE; MEDICAL ASSESSMENT; MELANOMA; MICROVASCULATURE; PROTEIN EXPRESSION; SKIN METASTASIS; TUMOR CELL; TUMOR VASCULARIZATION;

ADULT; AGED; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645541894     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020600557565     Document Type: Article

References (28)

1. Rak J, Filmus J, Kerbel RS. reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer 1996; 32A: 2438-50.
2. Marcoval J, Moreno A, Graells J, et al. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol 1997; 24: 212-8.
3. Potti A, Moazzam N, Tendulkar K, Javed NA, Koch M, Kargas S. Immunohistochemical Determination of vascular endothelial growth factor (vEGF) overexpression in malignant melanoma. Anticancer Res 2003; 23: 4023-6.
4. Takahashi Y, Tucker SL, Kitadai Y, et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 1997; 132: 541-6.
5. Fallowfield ME, Cook MG. The vascularity of primary cutaneous melanoma. J Pathol 1991; 164: 241-4.
6. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularisation in human cutaneous melanoma: a quantitative morphological and doppler ultrasound study. Eur J Cancer Clin Oncol 1986; 22: 1205-9.
7. Neitzel LT, Neitzel CD, Magee KL, Malafa MP. Angiogenesis correlates with metastasis in melanoma. Ann Surg Oncol 1999; 6: 70-4.
8. Srivastava A, Laidler P, Davies R, Morgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologie study. Am J Pathol 1988; 133: 419-23.
9. Ribatti D, Vacca A, Palma W, Lospalluti M, Dammacco F. Angiogenesis during tumor progression in human malignant melanoma. EXS 1992; 61: 415-20.
10. Barnhill RL, Fandrey K, Levy MA, Mihm M, Hyman B. Angiogenesis and tumor progression of melanoma. quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 1992; 67: 331-7.
11. Busam KJ, Berwick M, Blessing K, et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995; 147: 1049-56.
12. Vacca A, Ribatti D, Roncali L, et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993; 72: 455-61.
13. Cockerell CJ, Sonnier G, Kelly L, Patel S. Comparative analysis of neovascularization in primary cutaneous melanoma and spitz nevus. Am J Dermatopathol 1994; 16: 9-13.
14. Carnochan P, Briggs JC, Westbury G, Davies AJS. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25mm in thickness. Br J Cancer 1991; 64: 102-7.
15. Graham CH, Rivers J, Kerbel RS, Stamkiewicz KS, White WL. Extent of vascularization as a prognostic indicator in thin (<0.76mm) malignant melanomas. Am J Pathol 1994; 145: 510-4.
16. Salven P, Heikkila P, Joensuu H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 1997; 76: 930-4.
17. Al-Alousi S, Barnhill R, Blessing K, Barksdale S. The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma. J Cutan Pathol 1996; 23: 506-10.
18. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/ endotelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120-4.
19. Rongioletti F, Miracco C, Gambini C, Pastorino A, Tosi P, Rebora A. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4mm) cutaneous melanoma. Am J Dermatol 1996; 18: 474-7.
20. Claffey KP, Brown LF, del Aguila LF, et al. Expression of vascular permability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996; 56: 172-81.
21. Goydos JS, Gorski DH. Vascular endothelial growth factor C mRNA expression correlates with stages of progression in patients with melanoma. Clin Cancer Res 2003; 9: 5962-7.
22. Redondo P, Sanchez-Carpintero I, Bauza A, Idoate M, Solano T, Mihm M. Immunologic escape and angiogenesis in human malignant melanoma. J Am Acad Dermatol 2003; 49: 255-63.
23. Pötgens AJ, Lubsen NH, Van Altena MC, Schoenmaakers JGG, Ruiter DJ, de Waal RMW. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 1995; 146: 197-209.
24. Halaban R. Growth factors and tyrosine protein kinases in normal and malignant melanocytes. Cancer Metastasis Rev 1991; 10: 129-40.
25. Schulze-Osthoff K, Risau W, Vollmer E, Sorg C. In situ detection of bFGF by highly specific antibodies. Am J Pathol 1990; 137: 85-92.
26. Meier F, Nesbit M, Hsu MY, et al. Human melanoma progression in skin reconstructs. Biological significance of bFGF. Am J Pathol 2000; 156: 193-9.
27. Ribatti D, Vacca A, Ria R, et al. Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tyrptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 2003; 39: 666-74.
28. Reed JA, McNutt S, Albino AP. Differential expression of basic fibroblastic growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. implications for tumor progression. Am J Pathol 1994; 144: 329-36.